Search Result "STAT overactivation"
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 221-233
Author(s): Kakasaheb Ramoo Mahadik
Ruxolitinib Regulates the Autophagy Machinery in Multiple Myeloma Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 18 Year: 2020 Page: 2316-2323
Author(s): Alican Kusoglu,Bakiye G. Bagca,Neslihan P.O. Ay,Guray Saydam,Cigir B. Avci
Pulmonary Fibrosis; Risk Factors and Molecular Triggers, Insight for NeoTherapeutic Approach
Journal: Current Respiratory Medicine Reviews
Volume: 18 Issue: 4 Year: 2022 Page: 259-266
Author(s): Basheer Abdullah Marzoog
Cinnamic Acid Derivatives as Inhibitors of Oncogenic Protein Kinases â Structure, Mechanisms and Biomedical Effects#
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 10 Year: 2016 Page: 954-982
Author(s): Marcin Mielecki,Bogdan Lesyng
Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 1033-1040
Author(s): F. Meriggi, B. Di Biasi, C. Abeni, A. Zaniboni
Protein Kinases and their Modulation in the Central Nervous System
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3 Issue: 4 Year: 2003 Page: 341-364
Author(s): S. Sardari, F. Pourmorad, A. Tiemoa, N. H. Nam, K. Parang
Targeting Immune Signaling Pathways in Clonal Hematopoiesis
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5262-5277
Author(s): Nessar Ahmad Azrakhsh,Patrycja Mensah-glanowska,Kristoffer Sand,Astrid Olsnes Kittang
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 9 Year: 2014 Page: 1615-1626
Author(s): Julio C. Tobon-Velasco,Elvis Cuevas,Mónica A. Torres-Ramos
Why do Athletes Develop Very Severe or Fatal Forms of COVID afterIntense Exercise Following SARS-CoV-2 Infection or Anti-COVIDVaccination?
Journal: Infectious Disorders - Drug Targets
Volume: 23 Issue: 4 Year: 2023 Page: 11-15
Author(s):
Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 690-704
Author(s): M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland, G. Vitale